BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35871131)

  • 1. ARPC1A is regulated by STAT3 to inhibit ferroptosis and promote prostate cancer progression.
    Ji J; Li H; Wang W; Yuan B; Shen T
    Hum Cell; 2022 Sep; 35(5):1591-1601. PubMed ID: 35871131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ARPC1A correlates with poor prognosis in prostate cancer and is up-regulated by glutamine metabolism to promote tumor cell migration, invasion and cytoskeletal changes.
    Chen YH; Chen H; Lin TT; Zhu JM; Chen JY; Dong RN; Chen SH; Lin F; Ke ZB; Huang JB; Wei Y; Zheng QS; Xue XY; Xu N
    Cell Biosci; 2023 Feb; 13(1):38. PubMed ID: 36814338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer.
    Zhang H; Ge Z; Wang Z; Gao Y; Wang Y; Qu X
    Aging (Albany NY); 2021 Mar; 13(6):8115-8126. PubMed ID: 33686957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
    Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the 7q21-q22 amplicon identifies ARPC1A, a subunit of the Arp2/3 complex, as a regulator of cell migration and invasion in pancreatic cancer.
    Laurila E; Savinainen K; Kuuselo R; Karhu R; Kallioniemi A
    Genes Chromosomes Cancer; 2009 Apr; 48(4):330-9. PubMed ID: 19145645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Tumor Effects of Astaxanthin by Inhibition of the Expression of STAT3 in Prostate Cancer.
    Sun SQ; Zhao YX; Li SY; Qiang JW; Ji YZ
    Mar Drugs; 2020 Aug; 18(8):. PubMed ID: 32784629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated signal transducers and activators of transcription 3 signaling induces CD46 expression and protects human cancer cells from complement-dependent cytotoxicity.
    Buettner R; Huang M; Gritsko T; Karras J; Enkemann S; Mesa T; Nam S; Yu H; Jove R
    Mol Cancer Res; 2007 Aug; 5(8):823-32. PubMed ID: 17699108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fer tyrosine kinase cooperates with interleukin-6 to activate signal transducer and activator of transcription 3 and promote human prostate cancer cell growth.
    Zoubeidi A; Rocha J; Zouanat FZ; Hamel L; Scarlata E; Aprikian AG; Chevalier S
    Mol Cancer Res; 2009 Jan; 7(1):142-55. PubMed ID: 19147545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESTAT3 Inhibitor AG-490 Inhibits the Growth of Prostate Cancer by miR-503-5p Both In Vivo and In Vitro.
    Tan G; Jiang L; Li G; Bai K
    Technol Cancer Res Treat; 2020; 19():1533033820948062. PubMed ID: 33063634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Up-regulation of miR-124 inhibits invasion and proliferation of prostate cancer cells through mediating JAK-STAT3 signaling pathway.
    Wu Z; Huang W; Chen B; Bai PD; Wang XG; Xing JC
    Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2338-2345. PubMed ID: 28617558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1.
    Ma JB; Bai JY; Zhang HB; Jia J; Shi Q; Yang C; Wang X; He D; Guo P
    Cell Death Dis; 2020 Jun; 11(6):466. PubMed ID: 32546700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells.
    Hahm ER; Singh SV
    Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling.
    Zhang Y; Guo S; Wang S; Li X; Hou D; Li H; Wang L; Xu Y; Ma B; Wang H; Jiang X
    Ecotoxicol Environ Saf; 2021 Sep; 220():112376. PubMed ID: 34051661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription factor Stat3 stimulates metastatic behavior of human prostate cancer cells in vivo, whereas Stat5b has a preferential role in the promotion of prostate cancer cell viability and tumor growth.
    Gu L; Dagvadorj A; Lutz J; Leiby B; Bonuccelli G; Lisanti MP; Addya S; Fortina P; Dasgupta A; Hyslop T; Bubendorf L; Nevalainen MT
    Am J Pathol; 2010 Apr; 176(4):1959-72. PubMed ID: 20167868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 signaling drives EZH2 transcriptional activation and mediates poor prognosis in gastric cancer.
    Pan YM; Wang CG; Zhu M; Xing R; Cui JT; Li WM; Yu DD; Wang SB; Zhu W; Ye YJ; Wu Y; Wang S; Lu YY
    Mol Cancer; 2016 Dec; 15(1):79. PubMed ID: 27938379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
    Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
    Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.
    Moreira D; Zhang Q; Hossain DM; Nechaev S; Li H; Kowolik CM; D'Apuzzo M; Forman S; Jones J; Pal SK; Kortylewski M
    Oncotarget; 2015 Jul; 6(19):17302-13. PubMed ID: 26046794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of hub genes for lymph node metastasis in patients with prostate cancer.
    Xu N; Chen SH; Lin TT; Cai H; Ke ZB; Dong RN; Huang P; Li XD; Chen YH; Zheng QS
    J Cell Mol Med; 2020 Apr; 24(8):4402-4414. PubMed ID: 32130760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.